In human colon cancer (CRC), inhibition of SUV39H1 significantly increases the expression of granulozyme B, perforin, FasL, and IFN, inducing tumor cell apoptosis by enhancing immune surveillance and the killing effect of CTL (Lu et al., 2019). This evidence concerns the gene PRF1 and colorectal carcinoma.